A common polymorphism of the SRD5A2 gene and transsexualism

Reproductive Sciences

Volumn 14, Issue 7, 2007, Pages 705-709

  Bentz, Eva Katrin ^a   Schneeberger, Christian ^a   Hefler, Lukas A ^a   Van Trotsenburg, Mick ^b   Kaufmann, Ulrike ^a   Huber, Johannes C ^a   Tempfer, Clemens B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Gender; Polymorphism; Sex steroids; SRD5A2; Steroid 5 reductase; Transsexualism

Indexed keywords

ANDROGEN; LEUCINE; STEROID 5ALPHA REDUCTASE 2; VALINE; STEROID 5ALPHA REDUCTASE;

ANDROGEN METABOLISM; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE TO MALE TRANSSEXUAL; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE TO FEMALE TRANSSEXUAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SRD5A2 GENE; TRANSSEXUALISM; ALLELE; CASE CONTROL STUDY; ENZYMOLOGY; GENETICS;

ALLELES; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TESTOSTERONE 5-ALPHA-REDUCTASE; TRANSSEXUALISM;

EID: 38449106884     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719107306230     Document Type: Article

References (13)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4 th ed. Washington, DC: American Psychiatric Association ; 1994.
2. Brown GR A review of clinical approaches to gender dysphoria. J Clin Psychiatry. 1990 ; 51: 57-64.
3. Dorner G., Poppe I., Stahl F., Kolzsch J., Uebelhack R. Gene-and environment-dependent neuroendocrine etiogenesis of homosexuality and transsexualism. Exp Clin Endocrinol. 1991 ; 98: 141-150.
4. Zhou JN, Hofman MA, Gooren Ljg, Swaab DF A sex difference in the human brain and its relation to transsexuality. Nature. 1995 ; 378: 68-70.
5. Labrie F., Sugimoto Y., Luu-The V., et al. Structure of human type II 5 alpha-reductase gene. Endocrinology. 1992 ; 131: 1571-1573.
6. Yang C., Hamajima N., Iwata H., et al. A49T, V89L and TA repeat polymorphisms of steroid 5-alpha-reductase type II and breast cancer risk in Japanese women. Breast Cancer Res. 2002 ; 4 (4). R8.
7. van Gils CH, Onland-Moret NC, Roest M., van Noord PA, Peeters PH The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2003 ; 12: 1194-1199.
8. Nam RK, Toi A., Vesprini D., et al. V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology. 2001 ; 75: 199-204.
9. Lunn RM, Bell DA, Mohler JL, Taylor JA Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenesis. 1999 ; 20: 1727-1731.
10. Tempfer CB, Riener E., Hefler LA, Huber JC, Muendlein A. DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone therapy. Fertil Steril. 2004 ; 82: 132-137.
11. Huber M., Mundlein A., Dornstauder E., et al. Accessing single nucleotide polymorphisms in genomic DNA by direct multiplex polymerase chain reaction amplification on oligonucleotide microarrays. Ann Biochem. 2002 ; 303: 25-33.
12. Cohen-Kettenis PT, Gooren Ljg. Transsexualism: a review of etiology, diagnosis, and treatment. J Psychosom Res. 1999 ; 46: 315-333.
13. Landen M., Walinder J., Lundstrom B. Prevalence, incidence and sex ratio of transsexualism. Acta Psychiatr. 1996 ; 93: 221-223.